With Takeda’s £46 billion acquisition of Shire, it’s been a busy year for pharma M&A – and according to analysts Datamonitor, the specialist biotechs Nektar, BioMarin and Alnylam are the ...

This condition, known as pedal oedema, is more common than you think and can range from mild discomfort to a symptom of serious medical problems. Understanding what pedal oedema is, its causes ...

Four years after Bristol-Myers Squibb paid $1.85 billion upfront to make Nektar's bempegaldesleukin a companion drug to its cancer immunotherapy Opdivo, the alliance is being discontinued.

Trish Ruggiero follows her daughter, Gianna Ruggiero, 4, both of Hollidaysburg, on the sidewalk along Union Street on Thursday afternoon. Norfolk Southern reached an agreement with one of two ...